B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

APC/C:Cdc20 mediated degradation of Cyclin B

REACTOME PATHWAY
Reactome: R-HSA-1740482 genes16 compounds

The APC/C:Cdc20 mediated degradation of Cyclin B pathway (Reactome ID: R-HSA-174048) involves 2 genes and is affected by 16 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

CCNB1CDK1

Compounds Affecting APC/C:Cdc20 mediated degradation of Cyclin B

#CompoundTargets HitStudies
1kenpaullone8
2alsterpaullone12
3indirubin300
4Apigenin 5,7,4'-trihydroxy-flavone,300
5chrysin300
6fisetin78
7Luteolin 5,7,3',4'-tetrahydroxy-flavone,150
8Clofibrate299
9Fenofibrate297
10Sertraline1,000
11Cinnarizine299
12Clotrimazole296
13Rotenone300
14Quercetin300
15Sorafenib300
16sp600125117

About the APC/C:Cdc20 mediated degradation of Cyclin B Pathway

The APC/C:Cdc20 mediated degradation of Cyclin B pathway is catalogued in Reactome (ID: R-HSA-174048) and involves 2 genes. In the BiohacksAI corpus, 16 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include CCNB1, CDK1.